• +15302400250
  • support@medicalrecordsreview.com
  • 51 Pleasant St, 1118 Malden, MA 02148 United States
DMCA.com Protection Status
Upload Case

Head and Neck Cancer

Evaluation of
Head and Neck Cancer

Cancers of the head and neck (H&N) are uncommon diseases. Each of the entities (lip, oral cavities, oropharynx, nasal cavities, main salivary glands, salivary gland-type tumors, hypopharynx, and larynx) that make up the H&N group has an incidence rate of less than 6 per 100,000 and a prevalence rate of less than 5 per 10,000. Head and neck squamous cell carcinoma (HNSCC), which develops from the cells lining the inside of the nostrils, mouth, and throat. Typically expands to distant sites via direct extension, lymph nodes, and blood vessels.

No.of Medico-Legal Cases

98 Cases Handled
Medical Records Review Specialists

14 Specialists Available
Last Upadte

26 March, 2023

Examining the medicolegal factors of Head and Neck Cancer

There are various medicolegal issues that can arise in cases of head and neck cancer, such as the potential for medical malpractice claims, informed consent, and the use of medical devices. Moreover, there are also ethical considerations, including end-of-life care and patient autonomy.

Target Cancer Cells

Concurrent platinum-based chemoradiation, with surgery reserved for residual disease

Destroy cancer cells

Surgery with neck dissection and reconstruction, followed by adjuvant radiation or chemoradiation, depending on the presence of adverse risk factors

Chemotherapy

Induction chemotherapy followed by definitive chemoradiation and/or surgery Approximately 60% of patients with HNSCC present at a locally advanced stage, in which combined modality therapy with curative intent is recommended

Carcinogen exposure

The carcinogen exposure increases the HNSCC risk because the carcinogens smoke has genotoxic effects